Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

572 results about "Capillary vessels" patented technology

Raman spectroscopy for non-invasive glucose measurements

The present invention relates to the use of Raman spectroscopy for quantitative, non-invasive transcutaneous measurement of blood analytes, such as glucose. Raman spectroscopy is used to measure glucose transcutaneously, in patients whose blood glucose levels were monitored. Raman spectra were collected transcutaneously along with glucose reference values provided by standard capillary blood analysis. A partial least squares calibration was created from the data from each subject and validated using leave-one-out cross validation.
Owner:MASSACHUSETTS INST OF TECH

Scaffold for tissue engineering, artificial blood vessel, cuff, and biological implant covering member

The invention provides a porous scaffold for tissue engineering which allows easy cell engraftment and cell culture and thus enables stable organization and an artificial blood vessel which exhibits high patency rate even if the inner diameter is small. The scaffold for tissue engineering is made of thermoplastic resin which forms a porous three-dimensional network structure having communication property, wherein the porous three-dimensional network structure has an average pore diameter of from 100 to 650 μm and an apparent density of from 0.01 to 0.5 g/cm3. The artificial blood vessel is composed of this scaffold.
The invention provides a cuff which allows easy infiltration of cells from living subcutaneous tissues, easy engraftment of cells, and neovascularization of capillary vessels so as to obtain robust bonding with subcutaneous tissues and, as a result, ensures separation of a wounded portion from the outside, thereby blocking exacerbation factors such as bacterial infection on healing and inhibiting progression of downgrowth. That is, the invention provides a cuff with none or little infection trouble such as tunnel infection. The cuff comprises a porous three-dimensional network structure which is made of thermoplastic resin or thermosetting resin and has communication property, wherein the porous three-dimensional network structure has an average pore diameter of from 100 to 1000 μm and apparent density of from 0.01 to 0.5 g/cm3.
The invention provides a biological implant covering member which allows easy infiltration of cells from living subcutaneous tissues, easy engraftment of cells, and organization, thereby obtaining robust bonding with native tissues and therefore protecting a living body from adverse effect which may occur due to the insertion of a biological implantation member into the living body. The biological implant covering member comprises a porous three-dimensional network structure which is made of thermoplastic resin or thermosetting resin and has communication property, wherein the porous three-dimensional network structure has an average pore diameter of from 100 to 1000 μm and apparent density of from 0.01 to 0.5 g/cm3.
Owner:JAPAN AS REPRESENTED BY PRESIDENT OF NAT CARDIOVASCULAR +2

Electrophoresis apparatus having at least one auxiliary buffer passage

An electrophoresis apparatus is generally disclosed for sequentially analyzing a single sample or multiple samples having one or more analytes in high or low concentrations. The apparatus comprises a relatively large-bore transport capillary which intersects with a plurality of small-bore separation capillaries and includes a valve system. Analyte concentrators, having antibody-specific (or related affinity) chemistries, are stationed at the respective intersections of the transport capillary and separation capillaries to bind one or more analytes of interest. The apparatus allows the performance of two or more dimensions for the optimal separation of analytes. The apparatus may also include a plurality of valves surrounding each of the analyte concentrators to localize each of the concentrators to improve the binding of one or more analytes of interest.
Owner:PRINCETON BIOCHEM

External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof

The invention provides an external traditional Chinese medicine preparation for treating chronic wounds, which is prepared from the following raw medicines in parts by weight: 10-20 parts of draconis sanguis, 10-20 parts of chuanxiong rhizome, 10-20 parts of notoginseng, 10-20 parts of fried sanguisorba, 10-20 parts of safflower, 10-20 parts of spatholobus stem, 10-20 parts of giant knotweed, 10-20 parts of oldenlandia, 10-20 parts of red sage root, 10-20 parts of herba patriniae, 10-20 parts of moutan bark, 10-20 parts of myrrh, 10-20 parts of mastic, 10-20 parts of rhubarb, 10-20 parts of natural indigo, 10-20 parts of gromwell, 10-20 parts of catechu, 10-20 parts of borneol, 10-20 parts of phellodendron bark and 10-20 parts of boneset. The external traditional Chinese medicine preparation provided by the invention can promote healing of infectious wounds, increase pus, enhance qualitative viscosity and regenerate granulation to enable the wounds to quickly heal, has an obvious effect on treating wound infection, and can be used for treating partial ulcer, removing necrotic tissue and promoting granulation, accelerating the degeneration process of the necrotic tissue, promoting dilation of capillary vessels, accelerating microcirculation of the capillary vessels and filling the wounds.
Owner:李惠斌

Gadolinium-containing silicon dioxide nanosphere magnetic resonance contrast agent and preparation method thereof

The invention relates to a gadolinium-containing silicon dioxide nanosphere magnetic resonance contrast agent for lymphatic system specific imaging and a preparation method thereof. The contrast agent is nanosphere suspend liquid or powder formed by using water-soluble silicon dioxide to cover preparation containing gadolinium, wherein the particle size ranges from 50nm to 200nm; the weight ratio of the preparation containing gadolinium to the water-soluble silicon dioxide is between 1.86X10<-4> and 0.592. The nanosphere prepared by the invention has relatively high entrapment efficiency, can selectively enter Lymphatic capillaries but not capillary vessel, thereby being used for the lymphatic system specific imaging, reducing the interference of the capillary vessel, improving the sensitivity and specificity of the lymphatic qualitative diagnosis, as well as reducing the harm thereof to human body, therefore, the nanosphere magnetic resonance contrast agent is a new gadolinium-containing magnetic resonance contrast agent with high target.
Owner:SHANGHAI NAT ENG RES CENT FORNANOTECH

Product for treating myocardial infarction based on chitosan aquagel and growth factor

The invention discloses an injectable myocardial tissue engineering product based on temperature-sensitive chitosan aquagel. Concretely, the temperature-sensitive chitosan aquagel is used as a support material and carries one or a plurality of different blood vessel growth promotion factors, such as bFGF, PDGF-BB, VEGF, and the like, and the condition that the temperature-sensitive chitosan aquagel restores a myocardial infarction area is observed after the temperature-sensitive chitosan aquagel is injected and transplanted to the specific area of an animal myocardial infarction model. The temperature-sensitive myocardial tissue engineering product established by applying the support material can promote the growth of myocardial capillary vessels and arteriolae, can increase the growth of sarcogenic fibres, can promote the regeneration of myocardial tissues, can increase the locular wall thickness of the infarction area, can remodel the shape of an original ventricle and can improve the function of the heart. The invention has simple operation technology and mild enforcement condition, provides a new product for the myocardial tissue engineering and has an important meaning for the clinical development of treating heart diseases to tissue engineering cardiac muscles.
Owner:INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products